FDA Generic Labeling Rule: PhRMA, GPhA Offer Degrees Of Dislike
Executive Summary
GPhA argues it would be impossible for ANDA applicants to unilaterally change their labels; Pfizer suggests FDA only allow one request for a proposed labeling change on a given safety issue at a time.
You may also be interested in...
US FDA Gets A New Lawyer: Rebecca Wood Named Chief Counsel
Former Sidley Austin partner brings a wealth of experience in drug product liability litigation and federal preemption. She replaces agency veteran Elizabeth Dickinson, who will stay on as senior deputy to the chief counsel.
US FDA Gets A New Lawyer: Rebecca Wood Named Chief Counsel
Former Sidley Austin partner brings a wealth of experience in drug product liability litigation and federal preemption. She replaces agency veteran Elizabeth Dickinson, who will stay on as senior deputy to the chief counsel.
Gottlieb Q&A: Sen. Murray Wants To Know About Generic Labeling Rule
US FDA Commissioner nominee offers master class in how to respond to congressional inquiries – and throws in some policy insight for good measure.